Christophe Bourdon's time at Danish meme stock Orphazyme, which has a rejected rare disease drug, will come to a head in March. He will assume the helm at Leo Pharma as it prepares to launch its eczema drug.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,